SCHEMBL6676689

SCHEMBL6676689

CN(C)c1cccc(C(=O)Nc2ccc(F)c([N+](=O)[O-])c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.59
MCL1 Q07820 1/20 0.59
MAPK14 Q16539 3/20 0.57
MEN1 O00255 7/20 0.56
KMT2A Q03164 7/20 0.56
RAB9A P51151 2/20 0.56
MAPK1 P28482 1/20 0.56
LMNA P02545 6/20 0.56
HTT P42858 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
RAF1 P04049 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
BRAF P15056 1/20 0.51
ALOX15 P16050 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5897734 0.87 MAPT (0.60) MAPTMAPK14MEN1KMT2ARAB9A
SCHEMBL1455699 0.86 MEN1 (0.58) MAPTMAPK14MEN1KMT2ARAB9A
SCHEMBL1455951 0.84 MAPT (0.63) MAPTMCL1MEN1KMT2ARAB9A
SCHEMBL1454593 0.82 MEN1 (0.72) MAPTMCL1MEN1KMT2ARAB9A
SCHEMBL1454748 0.82 MAPT (0.63) MAPTMCL1MEN1KMT2ARAB9A
SCHEMBL1454512 0.81 MAPT (0.59) MAPTMCL1MEN1KMT2ARAB9A
SCHEMBL6787077 0.81 MEN1 (0.75) MAPTMEN1KMT2ARAB9ALMNA
SCHEMBL6681161 0.81 MAPK14 (0.61) MAPTMAPK14RAB9AHTTSMN1; SMN2
SCHEMBL811365 0.80 MAPT (0.60) MAPTMCL1MEN1KMT2ARAB9A
SCHEMBL6813549 0.80 MEN1 (0.70) MAPTMCL1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1188389-C Benzamide derivatives for the treatment of diseases mediated by cytokines ASTRA ZENECA LTD (SE) 2005-02-09 CN disclosed
EP-1077930-B1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES ASTRAZENECA AB (SE) 2004-11-10 EP disclosed
US-6465455-B1 TUMOUR NECROSIS FACTOR AND INTERLEUKIN FAMILY INHIBITORS; INHIBITION OF ENZYME P38 KINASE; INFLAMMATION, IMMUNO-REGULATION, ALLERGIES ASTRAZENECA AB (SE) 2002-10-15 US disclosed
CN-1359371-A Benzamide derivatives for the treatment of diseases mediated by cytokines ASTRA ZENECA LTD (SE) 2002-07-17 CN disclosed
EP-1077930-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES AstraZeneca AB (SE) 2001-02-28 EP disclosed
WO-1999059960-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES ASTRAZENECA AB (SE) 1999-11-25 WO disclosed